Heparin-Induced Osteopenia: An Appraisal (Q34945352)

5 August 2017

1 reference

title

Heparin-induced osteopenia: an appraisal (English)

1 reference

5 August 2017

L. V. Avioli

1

0 references

language of work or name

English

0 references

publication date

1 January 1975

1 reference

PubMed ID

123694

full work available at URL

5 August 2017

http://link.springer.com/content/pdf/10.1007/978-1-4684-0946-8_33.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

Advances in Experimental Medicine and Biology

2 May 2022

published in

1 reference

5 August 2017

52

1 reference

5 August 2017

375-387

1 reference

The effect of protamine derivatives on calcium metabolism in patients with malignancy

5 August 2017

2

21

48

JR Anderson

1967

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

Collagen metabolism, uremia and bone

2 May 2022

3

4

105

L Avioli

1973

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

Progress in endocrinology and metabolism. Vitamin D: current concepts

2 May 2022

4

22

507

L Avioli

1973

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

5-Hydroxytryptamine in mast cells.

2 May 2022

5

90

303

EP Benditt

1955

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

Hydralazine-induced disturbances in collagen biosynthesis

2 May 2022

6

271

125

RS Bhatnagar

1972

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

PANEL DISCUSSION. II. THE CLINICAL USAGE OF HEPARIN

2 May 2022

10

14

53

EG Dimond

1964

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

EFFECTS OF THE LONG-TERM ADMINSTRATION TO ANIMALS OF DEXTRAN SULPHATE

2 May 2022

11

89

437

HA Ellis

1965

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts

2 May 2022

14

162

570

JC Frantantoni

1968

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

HEPARIN ENHANCEMENT OF FACTORS STIMULATING BONE RESORPTION IN TISSUE CULTURE

2 May 2022

16

147

407

P Goldhaber

1965

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

Isolation and partial characterization of highly purified protocollagen proline hydroxylase

2 May 2022

20

198

460

H Halne

1970

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

SOME STUDIES ON MUCOSUBSTANCES OF BOVINE CORTICAL BONE

2 May 2022

21

89

405

GM Herring

1963

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

Comparison of continuous long-term heparin and oral anticoagulant therapy in patients with severe angina pectoris

2 May 2022

23

65

615

ML Hughes

1963

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

MULTIPLE FRACTURES ASSOCIATED WITH LONG-TERM SODIUM HEPARIN THERAPY

2 May 2022

series ordinal

24

0 references

Protamine-induced hypocalcemia.

25

87

1211

CC Johnston

1970

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

Calcium metabolism in response to heparin administration

2 May 2022

26

6

249

J Jowsey

1970

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

Lysyl-protocollagen hydroxylase deficiency in fibroblasts from siblings with hydroxylysine-deficient collagen

2 May 2022

27

69

2899

SM Krane

1972

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

Proteolytic enzymes of mast cells

2 May 2022

29

103

185

D Lagunoff

1963

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

The heparitin sulfates (heparan sulfates)

2 May 2022

31

29

41

A Linker

1973

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

Inhibition of protocollagen proline hydroxylase by Dilantin

2 May 2022

32

142

253

TZ Liu

1973

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

Osteoporosis resulting from heparin therapy. Report of a case

2 May 2022

33

33

31

WE Miller

1966

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

Effect of heparin and parathyroid extract on acid phosphatase in bone

2 May 2022

series ordinal

34

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

Inhibition of Bone Growth in vitro by Endotoxin: Histamine Effect

2 May 2022

37

221

469

LA Norton

1969

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

Sanfilippo syndrome: profound deficiency of alpha-acetylglucosaminidase activity in organs and skin fibroblasts from type-B patients

2 May 2022

38

69

1720

JS O’Brien

1972

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

The Anionic Polyelectrolyte, Polyethylene Sulphonate, as a New Anti-neoplastic Agent

2 May 2022

40

181

46

W Regelson

1958

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

The presence of histamine in tissue mast cells

2 May 2022

41

120

528

JF Riley

1953

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

The binding of thiosemicarbazide to collagen in vitro

2 May 2022

42

131

116

M Rojkind

1969

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

Effect of experimental chronic renal insufficiency on bone mineral and collagen maturation

2 May 2022

series ordinal

43

0 references

Abnormal bone mineral maturation in the chronic uremic state

44

52

2848

JE Russell

1973

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

Pathology of osteopathy following heparin therapy

2 May 2022

45

94

2334

J Schuster

1969

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

Inhibition of Collagen Intermolecular Cross-Linking by Thiosemicarbazide*

2 May 2022

50

5

1919

ML Tanzer

1966

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0946-8_33

2 May 2022

Identifiers

1 reference

National Center for Biotechnology Information

PubMed ID

123694

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=123694

5 December 2022

1 reference

PubMed ID

123694